Strides Pharma Science Limited has informed the Exchange about update on promoter reclassification request.
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Strides Pharma Science has informed the stock exchanges that its Board of Directors, at a meeting held on May 22, 2025, approved the reclassification request from Shasun Enterprises LLP and Ambemata Securities from the 'Promoter Group' to the 'Public' category. This follows an earlier intimation dated May 15, 2025 regarding the receipt of the request. The approval was granted in line with Regulation 31A of the SEBI Listing Regulations, and the company will now file the application with the stock exchanges to formalize the change. The Board noted the undertakings and confirmations provided by the outgoing promoters as part of the process.
This move shifts these two entities out of the promoter group, reducing the official promoter shareholding of the company and increasing the public shareholding category. For retail investors, this is a governance-level update and does not directly impact the stock price, but it changes the composition of who is classified as a promoter versus a public shareholder.